375 related articles for article (PubMed ID: 16935271)
1. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
Gomes CA; Vaz SH; Ribeiro JA; Sebastião AM
Brain Res; 2006 Oct; 1113(1):129-36. PubMed ID: 16935271
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor inhibits GABA uptake by the rat hippocampal nerve terminals.
Vaz SH; Cristóvão-Ferreira S; Ribeiro JA; Sebastião AM
Brain Res; 2008 Jul; 1219():19-25. PubMed ID: 18539266
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
4. GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.
Gomes CA; Simões PF; Canas PM; Quiroz C; Sebastião AM; Ferré S; Cunha RA; Ribeiro JA
J Neurochem; 2009 Mar; 108(5):1208-19. PubMed ID: 19141075
[TBL] [Abstract][Full Text] [Related]
5. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
Brambilla R; Cottini L; Fumagalli M; Ceruti S; Abbracchio MP
Glia; 2003 Aug; 43(2):190-4. PubMed ID: 12838511
[TBL] [Abstract][Full Text] [Related]
6. Adenosine A2A receptor activation is determinant for BDNF actions upon GABA and glutamate release from rat hippocampal synaptosomes.
Vaz SH; Lérias SR; Parreira S; Diógenes MJ; Sebastião AM
Purinergic Signal; 2015 Dec; 11(4):607-12. PubMed ID: 26452489
[TBL] [Abstract][Full Text] [Related]
7. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons.
Wirkner K; Gerevich Z; Krause T; Günther A; Köles L; Schneider D; Nörenberg W; Illes P
Neuropharmacology; 2004 Jun; 46(7):994-1007. PubMed ID: 15081796
[TBL] [Abstract][Full Text] [Related]
9. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
Jin S; Johansson B; Fredholm BB
J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
[TBL] [Abstract][Full Text] [Related]
10. Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors.
Pousinha PA; Diogenes MJ; Ribeiro JA; Sebastião AM
Neurosci Lett; 2006 Aug; 404(1-2):143-7. PubMed ID: 16790314
[TBL] [Abstract][Full Text] [Related]
11. The effect of GDNF on nigrostriatal dopaminergic function in response to a two-pulse K(+) stimulation.
Xu K; Dluzen DE
Exp Neurol; 2000 Dec; 166(2):450-7. PubMed ID: 11085910
[TBL] [Abstract][Full Text] [Related]
12. Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska K; Zylewska A
Pol J Pharmacol; 1997; 49(5):317-22. PubMed ID: 9566030
[TBL] [Abstract][Full Text] [Related]
13. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
Minghetti L; Greco A; Potenza RL; Pezzola A; Blum D; Bantubungi K; Popoli P
J Neuropathol Exp Neurol; 2007 May; 66(5):363-71. PubMed ID: 17483693
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
O'Neill C; Nolan BJ; Macari A; O'Boyle KM; O'Connor JJ
Eur J Neurosci; 2007 Dec; 26(12):3421-8. PubMed ID: 18052983
[TBL] [Abstract][Full Text] [Related]
15. Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine.
Marti M; Manzalini M; Fantin M; Bianchi C; Della Corte L; Morari M
J Neurochem; 2005 Apr; 93(1):195-205. PubMed ID: 15773919
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
Lupica CR; Cass WA; Zahniser NR; Dunwiddie TV
J Pharmacol Exp Ther; 1990 Mar; 252(3):1134-41. PubMed ID: 2156991
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.
Kurokawa M; Kirk IP; Kirkpatrick KA; Kase H; Richardson PJ
Br J Pharmacol; 1994 Sep; 113(1):43-8. PubMed ID: 7812630
[TBL] [Abstract][Full Text] [Related]
18. Adenosine activating A(2A)-receptors coupled to adenylate cyclase/cyclic AMP pathway downregulates nicotinic autoreceptor function at the rat myenteric nerve terminals.
Duarte-Araújo M; Timóteo MA; Correia-de-Sá P
Neurochem Int; 2004 Oct; 45(5):641-51. PubMed ID: 15234106
[TBL] [Abstract][Full Text] [Related]
19. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
Melani A; Cipriani S; Vannucchi MG; Nosi D; Donati C; Bruni P; Giovannini MG; Pedata F
Brain; 2009 Jun; 132(Pt 6):1480-95. PubMed ID: 19359287
[TBL] [Abstract][Full Text] [Related]
20. In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered.
Airavaara M; Mijatovic J; Vihavainen T; Piepponen TP; Saarma M; Ahtee L
Synapse; 2006 May; 59(6):321-9. PubMed ID: 16437537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
